Nuformix Limited

Calculating rank

USPTO Granted Patents = 7

% Expired Patents = 71.4

EPO Patents = 2

Forward Citations = 6

Loading Chart...

4 inventors (with patents filed for the assignee):

Joanne Holland (7 out of 17 patents)

Christopher Frampton (6 out of 12 patents)

Daniel Gooding (5 out of 8 patents)

4. Alan Chorlton (5 out of 5 patents)

7 patents: Sort by Forward Citations

1. 9822066 - Tranilast compositions and cocrystals (2017-11-21),

2. 9532993 - Aprepitant L-proline solvates—compositions and cocrystals (2017-01-03),

3. 9512064 - Tranilast compositions and cocrystals (2016-12-06),

4. 9248196 - Rebamipide complexes and cocrystals (2016-02-02),

5. 9029369 - Aprepitant L-proline composition and cocrystal (2015-05-12),

6. 8871793 - Metaxalone cocrystals (2014-10-28),

7. 8779146 - Cilostazol cocrystals and compositions (2014-07-15),

Company Overview

Nuformix Limited is a pharmaceutical development company focused on discovering and developing new uses for existing drugs through cocrystal technology. Their innovative approach has the potential to create novel formulations that improve drug efficacy, safety, and patient outcomes. Nuformix aims to address unmet medical needs and create value for patients, partners, and shareholders through their research and development efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#169 in

#2,345 in United Kingdom

GB

Nuformix Limited

Forward Citations = 6

4 inventors:

Joanne Holland (7 out of 17 patents)

Christopher Frampton (6 out of 12 patents)

Daniel Gooding (5 out of 8 patents)

4. Alan Chorlton (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nuformix Limited. Retrieved from https://idiyas.com/company/nuformix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]